<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">297</article-id>
      <article-id pub-id-type="doi">10.31348/2023/31</article-id>
      <article-categories>
        <subj-group>
          <subject>Case report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Torpedo Maculopathy. A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Anwarzai Šulavíková</surname>
            <given-names>Zuzana</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4213-9479</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krásnik</surname>
            <given-names>Vladimír</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>20</day>
        <month>9</month>
        <year>2023</year>
      </pub-date>
      <issue>5</issue>
      <elocation-id>6</elocation-id>
      <abstract>
        <p>Aim: Torpedo maculopathy (TM) is an incidental, congenital retinal lesion. The typical clinical finding is a unilateral, symmetric, oval, hypopigmented lesion in the inferotemporal macula. In most cases, the lesion is along the horizontal raphe, is torpedo-shaped, and the nasal edge is directed into the foveola. The diagnosis is determined on the basis of its characteristic shape, localization and findings on optical coherence tomography (OCT). The etiology and pathogenesis of torpedo maculopathy is unclear, but it is believed to be a congenital defect of the retinal pigment epithelium (RPE). The aim of this publication is highlight this diagnosis and to present an incidental finding of torpedo maculopathy in an adult patient. Case report: A 30-year-old female patient reported for a routine eye examination. Fundus examination of the right eye revealed an oval hypopigmented lesion with a size of 1 disk diameter inferotemporally from the fovea, which was followed by a satellite lesion in the same axis directed into the foveola. Based on OCT, OCT angiography, fundus autofluorescence, and the typical shape and location of the lesion, the patient was diagnosed with torpedo maculopathy in the right eye. Conclusion: In general, torpedo maculopathy is an asymptomatic, congenital, benign retinal lesion, which is mostly diagnosed accidentally during a routine fundus examination. TM is non-progressive retinal finding with a minimal risk of deterioration of visual functions, which does not require any treatment. Nevertheless, due to the rare risk of a choroidal neovascular membrane, it is recommended to examine patients once a year. It is necessary to consider this diagnosis when a unilateral hypopigmented lesion is found inferotemporally from the fovea, and to distinguish it from chorioretinal atrophy, scar, vitelliform dystrophy, or other RPE lesions as part of the differential diagnosis.</p>
      </abstract>
      <kwd-group>
        <kwd>torpedo maculopathy</kwd>
        <kwd>hypopigmented nevus</kwd>
        <kwd>retina</kwd>
        <kwd>macula</kwd>
        <kwd>optical coherence tomography</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R3339">
        <mixed-citation>Roseman RL, Gass JD. Solitary hypopigmented nevus of the retinal pigment epithelium in the macula. Arch Ophthalmol. 1992;110:1762.</mixed-citation>
      </ref>
      <ref id="R3340">
        <mixed-citation>Menezes K, Mancera N, Patel H, Kattih Z, Mhaskar R. Torpedo Maculopathy: A Systematic Review of Case Reports. Ophthalmic Surg Lasers Imaging Retina. 2021;52(2):78-83.</mixed-citation>
      </ref>
      <ref id="R3341">
        <mixed-citation>Shirley K, O’Neill M, Gamble R, Ramsey A, McLoone E. Torpedo maculopathy: disease spectrum and associated choroidal neovascularization in a paediatric population. Eye. 2018;32:1315- 1320.</mixed-citation>
      </ref>
      <ref id="R3342">
        <mixed-citation>Venkatesh R, Jain K, Pereira A, Thirumalesh, Yadav NK. Torpedo Retinopathy. J Ophthalmic Vis Res. 2020;15(2):187-194.</mixed-citation>
      </ref>
      <ref id="R3343">
        <mixed-citation>Yuan H, Dou H, Li X. Multimodal Imaging of Choroidal Structural in Torpedo Macu-lopathy. Front Med (Lausanne). 2023;10.</mixed-citation>
      </ref>
      <ref id="R3344">
        <mixed-citation>Wong EN, Fraser-Bell S, Hunyor AP, Chen FK. Novel optical coherence tomography classification of torpedo maculopathy. Clin Exp Ophthalmol. 2015;43:342-348.</mixed-citation>
      </ref>
      <ref id="R3345">
        <mixed-citation>Tripathy K, Sarma B, Mazumdar S. Commentary: Inner retinal excavation in torpedo maculopathy and proposed type 3 lesions in optical coherence tomography. Indian J Ophthalmol. 2018;66(8):1213-1214.</mixed-citation>
      </ref>
      <ref id="R3346">
        <mixed-citation>Smith MJ, Sia DIT, Greve M. Torpedo maculopathy-inferior variant. Can J Ophthal-mol. Published:March 18, 2021 (Article in press) doi:https://doi.org/10.1016/j.jcjo.2021.02.008<pub-id pub-id-type="doi">10.1016/j.jcjo.2021.02.008</pub-id></mixed-citation>
      </ref>
      <ref id="R3347">
        <mixed-citation>Richez F, Gueudry J, Brasseur G, Muraine M. Maculopathie en torpille bilatérale [Bilateral torpedo maculopathy]. J Fr Ophtalmol. 2010;33(4):296. French.</mixed-citation>
      </ref>
      <ref id="R3348">
        <mixed-citation>Ranjith PC, Giridhar, Anantharaman. Hyperpigmented torpedo maculopathy. Indian Journal of Ophthalmology. 2019;67(2):270-</mixed-citation>
      </ref>
      <ref id="R3349">
        <mixed-citation>Knani L, Werda S, Ghachem M, Mahjoub A. Multimodal imaging of torpedo maculopathy with optical coherence tomography angiography. Saudi J Ophthalmol. 2023;37(1):63-65.</mixed-citation>
      </ref>
      <ref id="R3350">
        <mixed-citation>Byer M, Rousso L, Rodman J, Shechtman D. Case Report: Use of Multimodal Imaging to Document a Rare Complication of Torpedo Maculopathy. Optom Vis Sci. 2021;98(8):870-875.</mixed-citation>
      </ref>
      <ref id="R3351">
        <mixed-citation>Pian D, Ferrucci S, Anderson SF, Wu C. Paramacular coloboma. Optom Vis Sci. 2003;80:556-563.</mixed-citation>
      </ref>
      <ref id="R3352">
        <mixed-citation>Papastefanou VP, Vázquez-Alfageme C, Keane PA, Sagoo MS. Multimodality imaginf of torpedo maculopathy with swptsource, en face optical coherence tomography and optical coherence tomography angiography. Retin Cases Brief Rep. 2018;12(2):153-157.</mixed-citation>
      </ref>
      <ref id="R3353">
        <mixed-citation>Shields CL, Guzman JM, Shapiro MJ, Fogel LE, Shields JA. Torpedo Maculopathy at the Site of the Fetal “Bulge”. Arch Ophthalmol. 2010;128(4):499-501.</mixed-citation>
      </ref>
      <ref id="R3354">
        <mixed-citation>Soman J, Sheth JU, Indurkar A, Nair U. Torpedo Maculopathy Associated with RP1L1 Mutation and Rod-Cone Dystrophy. Acta Scientific Ophthalmology. 2021;138-141.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
